ARVN
Arvinas Inc
Price:  
10.85 
USD
Volume:  
1,289,358.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Arvinas EV/EBITDA

-284.3%
Upside

As of 2026-04-05, the EV/EBITDA ratio of Arvinas Inc (ARVN) is -4.76. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Arvinas's latest enterprise value is 551.47 mil USD. Arvinas's TTM EBITDA according to its financial statements is -115.80 mil USD. Dividing these 2 quantities gives us the above Arvinas EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 9.2x - 14.8x 11.7x
Forward P/E multiples 12.6x - 14.1x 12.8x
Fair Price (20.66) - (23.30) (20.00)
Upside -290.4% - -314.7% -284.3%
10.85 USD
Stock Price
(20.00) USD
Fair Price

Arvinas EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2026-04-02 -4.76
2026-04-01 -5.03
2026-03-31 -4.62
2026-03-30 -4.39
2026-03-27 -4.35
2026-03-26 -4.77
2026-03-25 -4.80
2026-03-24 -4.45
2026-03-23 -4.47
2026-03-20 -4.81
2026-03-19 -4.94
2026-03-18 -4.78
2026-03-17 -5.40
2026-03-16 -5.55
2026-03-13 -5.50
2026-03-12 -5.66
2026-03-11 -6.21
2026-03-10 -6.41
2026-03-09 -6.15
2026-03-06 -6.28
2026-03-05 -6.35
2026-03-04 -6.37
2026-03-03 -6.15
2026-03-02 -6.17
2026-02-27 -6.10
2026-02-26 -6.16
2026-02-25 -6.11
2026-02-24 -5.60
2026-02-23 -5.56
2026-02-20 -5.39
2026-02-19 -5.64
2026-02-18 -5.30
2026-02-17 -5.09
2026-02-13 -5.20
2026-02-12 -5.31
2026-02-11 -6.00
2026-02-10 -6.19
2026-02-09 -6.11
2026-02-06 -6.21
2026-02-05 -5.93
2026-02-04 -6.17
2026-02-03 -6.31
2026-02-02 -6.41
2026-01-30 -6.16
2026-01-29 -6.16
2026-01-28 -5.91
2026-01-27 -6.29
2026-01-26 -6.11
2026-01-23 -5.89
2026-01-22 -5.71